"Designing Growth Strategies is in our DNA"

U.S. Sexually Transmitted Disease Testing Market Size, Share & COVID-19 Impact Analysis, By Product Type (Instruments and Reagents & Kits), By Application (Chlamydia, Syphilis, Genital Herpes, Gonorrhea, Human Immunodeficiency Virus, Human Papillomavirus, and Others), By Setting (Laboratory Testing and Point-of-Care) By End User (Hospital & Clinics, Clinical Laboratories, and Others), and Country Forecast, 2023-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI108002

 


To get information on various segments, share your queries with us

  ATTRIBUTE

  DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year

2023

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate

CAGR of 8.7% from 2023 to 2030

Unit

Value (USD Billion)

Segmentation

By Product Type

  • Instruments
  • Reagents & Kits

By Application

  • Chlamydia
  • Syphilis
  • Genital Herpes
  • Gonorrhea
  • Human Immunodeficiency Virus
  • Human Papillomavirus (HPV)
  • Others

By Setting

  • Laboratory Testing
  • Point-of Care (POC)

By End User

  • Hospitals and Clinics
  • Diagnostic Centers
  • Others
  • 2019-2030
  • 2022
  • 2019-2021
  • 80
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase